| Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma Y Oba, GA Salzman Journal of allergy and clinical immunology 114 (2), 265-269, 2004 | 170 | 2004 |
| Abandoning daily routine chest radiography in the intensive care unit: meta-analysis Y Oba, T Zaza Radiology 255 (2), 386-395, 2010 | 165 | 2010 |
| Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis Y Oba, ST Sarva, S Dias Thorax 71 (1), 15-25, 2016 | 147 | 2016 |
| The use of corticosteroids in SARS Y Oba The New England journal of medicine 348 (20), 2034-2035, 2003 | 146 | 2003 |
| Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta‐analysis Y Oba, E Keeney, N Ghatehorde, S Dias Cochrane Database of Systematic Reviews, 2018 | 145 | 2018 |
| Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis Y Oba, NA Lone Therapeutic advances in respiratory disease 7 (1), 13-24, 2013 | 81 | 2013 |
| High levels of PEEP may improve survival in acute respiratory distress syndrome: a meta-analysis Y Oba, DM Thameem, T Zaza Respiratory medicine 103 (8), 1174-1181, 2009 | 76 | 2009 |
| The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review Y Oba, T Abu-Salah Respiration 83 (3), 198-208, 2012 | 75 | 2012 |
| Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. Y Oba, GA Salzman, SK Willsie Respiratory care 45 (4), 401-406, 2000 | 64 | 2000 |
| Community-acquired pneumonia H Regunath, Y Oba | 58 | 2017 |
| Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials Y Oba, NA Lone Journal of Critical Care 29 (5), 706-710, 2014 | 58 | 2014 |
| Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease Y Oba Mayo Clinic Proceedings 82 (5), 575-582, 2007 | 52 | 2007 |
| Safety, tolerability and risk benefit analysis of tiotropium in COPD Y Oba, T Zaza, DM Thameem International journal of chronic obstructive pulmonary disease 3 (4), 575-584, 2008 | 40 | 2008 |
| Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease. Y Oba The American journal of managed care 15 (2), 97-104, 2009 | 37 | 2009 |
| Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis Y Oba, NA Lone International Journal of Chronic Obstructive Pulmonary Disease, 469-479, 2014 | 35 | 2014 |
| Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD. Y Oba The American journal of managed care 15 (4), 226-232, 2009 | 32 | 2009 |
| Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression Y Oba, NA Lone Therapeutic advances in respiratory disease 9 (1), 3-15, 2015 | 25 | 2015 |
| Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry JPS Sawhney, VA Kothiwale, V Bisne, R Durgaprasad, P Jadhav, ... Indian heart journal 70 (6), 828-835, 2018 | 21 | 2018 |
| Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists DA Fitzmaurice, G Accetta, S Haas, G Kayani, H Lucas Luciardi, ... British journal of haematology 174 (4), 610-623, 2016 | 20 | 2016 |
| Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults … Y Oba, S Anwer, T Maduke, T Patel, S Dias Cochrane Database of Systematic Reviews, 2022 | 15 | 2022 |
